Statement from Ilana Golant, Founder and CEO of the Food Allergy Fund Food Allergy Fund Thanks ARPA-H for Prioritizing Allergic Disease
Today at the Food Allergy Fund Summit in New York City, Wade Shen, Director of Proactive Health at the Advanced Research Projects Agency for Health (ARPA-H), shared the agency’s strategic priorities for advancing research and innovation to prevent, mitigate, and delay diseases, including food allergies and other urgent health challenges. He encouraged the event’s attendees and the larger research community to engage with the agency as it helps to accelerate work on food allergies.
New York, NY — [April 30, 2025] — Today at the Food Allergy Fund Summit in New York City, Wade Shen, Director of Proactive Health at the Advanced Research Projects Agency for Health (ARPA-H), shared the agency’s strategic priorities for advancing research and innovation to prevent, mitigate, and delay diseases, including food allergies and other urgent health challenges. He encouraged the event’s attendees and the larger research community to engage with the agency as it helps to accelerate work on food allergies.
“On behalf of the Food Allergy Fund and our entire community, I extend my heartfelt thanks to Wade Shen and Dr. Jason Roos for affirming the agency’s commitment to making allergic diseases a national health priority. Your leadership in driving research into the root causes of food allergies is essential to our mission: to prevent, treat, and ultimately cure this chronic disease. ARPA-H’s bold, future-focused approach to funding transformative science reflects the growing recognition of food allergies as a serious and escalating public health issue.
“Food allergies are the canary in the coal mine for chronic disease and addressing them can unlock critical insights that can transform the future of public health. We are grateful for your partnership and dedication to advancing meaningful change for the millions of Americans affected by food allergies.”
###
About the Food Allergy Fund
The Food Allergy Fund (FAF) is the leading nonprofit dedicated to funding cutting-edge research to prevent, diagnose, and treat food allergies, a growing public health crisis affecting 10 percent of people in the United States and more than 300 million globally. Through innovative research grants and thought leadership summits, FAF is an incubator and convener, uniting scientists, policymakers, industry leaders, and entrepreneurs to drive breakthroughs. FAF’s mission is to create a future where no one has to suffer from food allergies. To learn more, visit www.foodallergyfund.org.
Media Contact: Press@foodallergyfund.org.
Food Allergy Fund Launches PSA to Empower Kids and Raise Awareness for Food Allergies
The Food Allergy Fund (FAF) is launching an engaging new Public Service Announcement (PSA) to empower kids and raise awareness about food allergies during Food Allergy Awareness Month this May. The PSA will debut across Nickelodeon’s platforms from May 1-31, and features Emmy Award-winning culinary social media sensation Tiny Chef (The Tiny Chef Show, produced by Imagine Entertainment and Nickelodeon Animation) alongside content creator Merrick Hanna, who has food allergies. This fast-growing disease affects 1 in 13 children and 1 in 10 adults in the U.S.
New York, NY (April 30, 2025) – The Food Allergy Fund (FAF) is launching an engaging new Public Service Announcement (PSA) to empower kids and raise awareness about food allergies during Food Allergy Awareness Month this May. The PSA will debut across Nickelodeon’s platforms from May 1-31, and features Emmy Award-winning culinary social media sensation Tiny Chef (The Tiny Chef Show, produced by Imagine Entertainment and Nickelodeon Animation) alongside content creator Merrick Hanna, who has food allergies. This fast-growing disease affects 1 in 13 children and 1 in 10 adults in the U.S.
Culinary Social Media Sensation Tiny Chef and Content Creator Merrick Hanna in Multiplatform PSA Launching on Nickelodeon During Food Allergy Awareness Month
“As founder and CEO of FAF, and a food allergy parent, I’m grateful to Nickelodeon for their creativity and support in spotlighting this growing public health crisis,” said Ilana Golant. “Food allergies affect 10 percent of Americans, and every three minutes, someone visits the ER due to an allergic reaction. Food allergies are not a lifestyle choice—they are a serious chronic health condition. Through awareness and simple actions, we can ensure kids with food allergies feel safe, included, and protected.”
Merrick Hanna, known for his viral dance videos, shares in the PSA, “I love to dance, but I also love to cook. The reason I cook is because I have serious food allergies. I have to be careful because every single bite counts. The truth is food allergies affect more people than you might realize—there are usually two kids in a classroom with food allergies.”
The PSA was unveiled today during the Food Allergy Fund’s Annual Summit, an event bringing together scientists, innovators, policymakers, and advocates to advance food allergy research and explore new ways to make living with food allergies easier. The event underscores the progress made in food allergy science over the past decade and the growing momentum to improve prevention, treatments and ultimately find a cure.
For more information about the PSA and how to get involved, visit www.foodallergyfund.org and follow @FoodAllergyFund @TheTinyChefShow, @Nickelodeon, @MerrickHanna, on social media.
###
Media Contacts:
Amy DiElsi: press@foodallergyfund.org
Maggie Wang/Nickelodeon: maggie.wang@nick.com
About Nickelodeon:
Nickelodeon, now in its 46th year, is the number-one entertainment brand for kids. It has built a diverse, global business by putting kids first in everything it does. The brand includes television programming and production in the United States and around the world, plus consumer products, digital, location-based experiences, publishing and feature films. For more information or artwork, visit http://www.nickpress.com. Nickelodeon is a part of Paramount’s (Nasdaq: PARA, PARAA) global portfolio of multimedia entertainment brands.
About the Food Allergy Fund:
The Food Allergy Fund (FAF) is the leading nonprofit dedicated to funding cutting-edge research to prevent, diagnose, and treat food allergies, a growing public health crisis affecting 10 percent of people in the United States and more than 300 million globally. Through innovative research grants and thought leadership summits, FAF is an incubator and convener, uniting scientists, policymakers, industry leaders, and entrepreneurs to drive breakthroughs. FAF’s mission is to create a future where no one has to suffer from food allergies. To learn more, visit www.foodallergyfund.org.
Food Allergy Fund Research Week Launches in April to Advance Life-Saving Solutions
With food allergies affecting 33 million Americans and causing a life-threatening reaction every three minutes, the Food Allergy Fund (FAF) is launching its inaugural Food Allergy Research Week from April 28-30 in New York City to drive support and accelerate breakthroughs in prevention and treatment ahead of Food Allergy Awareness Month, which begins May 1.
New York, NY (February 27, 2025) – With food allergies affecting 33 million Americans and causing a life-threatening reaction every three minutes, the Food Allergy Fund (FAF) is launching its inaugural Food Allergy Research Week from April 28-30 in New York City to drive support and accelerate breakthroughs in prevention and treatment ahead of Food Allergy Awareness Month, which begins May 1.
“Food allergies are a growing public health crisis and a chronic disease, and scientific research is key to transforming lives and preventing future cases,” said Ilana Golant, founder and CEO of FAF. “Significant progress has been made over the past decade, and we’re on the brink of breakthrough discoveries into the underlying causes, prevention and improved treatments. Food Allergy Fund Research Week is essential for building public support and partnerships to accelerate progress.”
During Food Allergy Fund Research Week, FAF will exclusively host:
FAF Annual Summit–This year’s Food Allergy Fund Summit, which will take place on April 30 at the Paley Center for Media in New York City, will unite key global stakeholders including leading doctors and scientists, CEOs of early-stage therapeutics and technology, government officials, advocates, industry and investors. Attendees will have the opportunity to learn from and network with speakers on the latest advancements in research, diet diversity, the microbiome, and cutting-edge technologies like AI and CRISPR.
FAF Research Retreat–A two-day private event for scientists and business leaders to share and develop collaborative research projects.
FAF Signature Research Evening–The Food Allergy Fund’s Signature Research Evening on April 29, 2025, will bring together leading experts, thought leaders, entrepreneurs, and philanthropists for meaningful discussions and updates from our Research Retreat.
Visit www.foodallergyfund.org to learn more and register for FAF’s Research Week, where you can meet the experts, ask questions, and discover what’s next for the food allergy community.
###
Media Contact: press@foodallergyfund.org
The Food Allergy Fund is the leading nonprofit dedicated to funding food allergy research. FAF's grants support the creation of new treatments that will address the root causes of food allergies. Through our groundbreaking research and unique thought leadership summits, we accelerate innovation to find solutions. To learn more, visit www.foodallergyfund.org.
Signature Research Evening
We are excited to invite you to a special evening supporting food allergy research where you will have the exclusive opportunity to meet researchers from around the world!
Register for the Food Allergy Fund’s Signature Research Evening on April 29, 2025—the eve of our annual Food Allergy Fund Summit.
We are excited to invite you to a special evening supporting food allergy research where you will have the exclusive opportunity to meet researchers from around the world!
Register for the Food Allergy Fund’s Signature Research Evening on April 29, 2025—the eve of our annual Food Allergy Fund Summit.
Join us for an intimate evening dedicated to exploring groundbreaking innovations in technology aimed at preventing, treating, and curing food allergies. This event will bring together leading experts, thought leaders, entrepreneurs, and philanthropists for meaningful discussions and to support vital research in the fight against food allergies. Guests will have the opportunity to learn about the work of our participants directly after hear the latest updates from our exclusive Research Retreat and meet the researchers involved.
###
The Food Allergy Fund is the leading nonprofit dedicated to funding food allergy research. FAF aims to identify underlying causes, discover new therapeutics, and improve the lives of all people living with food allergies. Through our ground-breaking research and unique thought leadership summits, we accelerate innovation to find solutions. To learn more, visit www.foodallergyfund.org.
Join the FAF Visionaries Circle
Be part of the new FAF Visionaries Circle! This exclusive giving group empowers and connects individuals and families impacted by food allergies.
Join us for our kick-off virtual event with Dr. Stephanie Eisenbarth on Monday, December 9, at 1 p.m. EST to learn more about the membership benefits.
Join the new FAF Visionaries Circle! This exclusive giving group empowers and connects individuals and families impacted by food allergies.
As a member of the Visionaries Circle, you’ll have the unique opportunity to:
Learn directly from leading doctors, scientists, and innovators in the field
Participate in exclusive events and programming in cities nationwide
Enjoy special access to our signature events, including the Food Allergy Fund Summit
VIRTUAL EVENT DETAILS
If you are interested in joining the Visionaries Circle, please rsvp below for our kick-off Zoom with Dr. Stephanie Eisenbarth on Monday, December 9, at 1 p.m. EST to learn more about the membership benefits.
One of the most rewarding aspects of building FAF has been the connections we’ve made with food allergy families, advocates, scientists, and leaders. While living with food allergies can often feel isolating and overwhelming—especially during the holidays—we’re constantly inspired by the sense of community we’ve created. There is hope for the future when we share our experiences and ideas and drive forward new research and innovations. We look forward to connecting with you in our Visionaries Circle.
###
The Food Allergy Fund is the leading nonprofit dedicated to funding food allergy research. FAF aims to identify underlying causes, discover new therapeutics, and improve the lives of all people living with food allergies. Through our ground-breaking research and unique thought leadership summits, we accelerate innovation to find solutions. To learn more, visit www.foodallergyfund.org.
SAVE THE DATE: Food Allergy Fund Summit, April 30, 2025
July 3, 2024 — The Food Allergy Fund is bringing back their successful #thisisnuts challenge on July 4th to raise awareness about food allergies and the need for research. Share your upside-down photos and videos to help us turn allergies upside down!
Save the date, April 30th, 2025 for our marquee annual Summit in New York City. Join us for an in-person experience, highlighting the latest advancements and
cutting-edge developments in food allergy research and innovation in 2025.
You don't want to miss our signature event! Details and registration to follow soon.
Food Allergy Fund Launches Exclusive Research Roadmap to Accelerate Food Allergy Prevention and a Cure
New York, NY (May 31, 2024) – The Food Allergy Fund (FAF), the leading nonprofit that funds food allergy research, has marked a significant milestone in the field: A first-ever Food Allergy Research Roadmap, a comprehensive guide designed to accelerate medical discovery and development progress within the next five years.
New York, NY (May 31, 2024) – The Food Allergy Fund (FAF), the leading nonprofit that funds food allergy research, has marked a significant milestone in the field: A first-ever Food Allergy Research Roadmap, a comprehensive guide designed to accelerate medical discovery and development progress within the next five years. FAF has brought together an exclusive working group of renowned scientists and allergists to identify the root causes of food allergies and focus on cutting-edge approaches to prevent, treat, and cure the disease. In addition, FAF’s Scientific Advisory Board is an unparalleled group of doctors and scientists from leading research institutions across the country.
While current food allergy research primarily targets disease symptoms and single-food immunotherapy treatments, FAF's Research Roadmap adopts a transformative approach. It prioritizes prevention and cures for multiple food allergies and allergic diseases, developing disease-modifying therapeutics, and catalyzing multiple proof-of-concept clinical trials. The FAF Research Roadmap will serve as a scientific business plan for scientists and funders.
Over the next five years, FAF will focus on eliminating anaphylactic reactions, inducing and maintaining immune tolerance to foods, and preventing food allergy in the next child or adult.
FAF's vision includes:
Forging partnerships between academia and industry
Utilizing AI-driven platforms
Recruiting new talent and medical disciplines
Hosting curated research retreats
Repurposing therapeutics
Creating a venture philanthropy platform to address the funding gap
Today, food allergies are a growing concern and a pressing public health issue. The incidence and severity are rising, with 1 in 10 adults and 1 in 13 children affected. More than forty percent of people with food allergies are allergic to multiple foods, and every three minutes, a person visits the emergency room due to an allergic reaction.
"The food allergy community has never had a real-time tool like this roadmap, and it is an essential next step in hastening our progress to find a cure for the disease," said Ilana Golant, founder and CEO of the Food Allergy Fund. "To end food allergies, we have assembled the brightest minds in America to help us map our goals, pool resources, and collaborate across disciplines, proactively changing the research culture."
The ground-breaking Research Roadmap was unveiled at the 9th Food Allergy Fund Summit, which brings together leading experts and advocates. The marquee summit, held at the Paley Center for Media in New York during Food Allergy Awareness Month in May, serves as a platform for sharing knowledge, fostering collaboration, and driving innovation in food allergy research.
Research Roadmap Working Group
Dr. Richard Insel, Research Professor, Department of Pediatrics, University of Rochester School of Medicine & Dentistry
Stephanie Eisenbarth, MD, PhD, Director, Center for Human Immunobiology; Chief of Allergy and Immunology in the Department of Medicine; Roy and Elaine Patterson Professor of Medicine; Professor of Medicine (Allergy and Immunology) and Pathology, Northwestern University
Dr. Rima Rachid, Director of Allergen Immunotherapy, Allergy and Asthma Program; Co-Director, Food Allergy Program, Boston Children’s Hospital; Attending Physician, Division of Immunology; Associate Professor of Pediatrics, Harvard Medical School
Dr. Marc Rothenberg, MD, PhD, Director, Division of Allergy and Immunology; Director, Cincinnati Center for Eosinophilic Disorders, Cincinnati Children’s Hospital
Scientific Advisory Board
Martin J. Blaser, M.D., Henry Rutgers Chair of the Human Microbiome; Professor, Department of Medicine and Microbiology; Director, Center for Advanced Biotechnology and Medicine RBHS, Robert Wood Johnson Medical School
Scott Boyd, M.D., Ph.D., Director, Boyd Lab for Human Immunology Member; Child Health Research Institute Member; Sean N. Parker Center for Allergy & Asthma Research; Associate Professor of Pathology Stanford University School of Medicine
Linda Herbert, Ph.D., Director, Psychosocial Clinical Program, Division of Allergy & Immunology; Assistant Professor, Division of Psychology & Behavioral Health Children's National Health System
Wayne I. Lencer, M.D., Chief, Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital; Director, Harvard Digestive Diseases Center; Longwood Professor of Pediatrics, Harvard Medical School
J. Christopher Love, Ph.D., Professor of Chemical Engineering, Massachusetts Institute of Technology (MIT); Associate Member, Broad Institute; Associate Member, Ragon Institute of MGH, MIT and Harvard
Rachel L. Miller, M.D., Merksamer Professor in Immunology; Chief, Division of Clinical Immunology, Icahn School of Medicine at Mount Sinai
Kari Nadeau, M.D., Ph.D., Chair, Department of Environmental Health, Harvard T.H. Chan School of Public Health
Noah Wolcott Palm, Ph.D., Assistant Professor of Immunobiology, Yale University School of Medicine
Hugh A. Sampson, M.D., Kurt Hirschhorn Professor of Pediatrics; Director Emeritus, Jaffe Food Allergy Institute; Past President, American Academy of Allergy, Asthma & Immunology, Icahn School of Medicine at Mount Sinai
Wayne G. Shreffler, M.D., Ph.D., Chief, Pediatric Allergy & Immunology; Director, Food Allergy Center, Massachusetts General Hospital; Associate Professor of Pediatrics, Harvard Medical School
Scott H. Sicherer, M.D., Director, Elliot and Roslyn Jaffe Food Allergy Institute; Chief, Division of Allergy and Immunology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai
Marsha Wills-Karp, Ph.D., Co-Chair, Consortium of Food Allergy Research (CoFAR) National Institutes of Health (NIH); Chair, Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health
Gary D. Wu, M.D., Director, Molecular Biology Core; Associate Chief for Research, Division of Gastroenterology; Associate Director, Center for Molecular Studies in Digestive and Liver Disease; Ferdinand G. Weisbrod Professor in Gastroenterology, Hospital of the University of Pennsylvania
###
Media Contact: Amy DiElsi, adielsi02@gmail.com, 215-990-3006
The Food Allergy Fund is the leading nonprofit dedicated to funding food allergy research. FAF's grants support the creation of new treatments that will address the root causes of food allergies. Through our groundbreaking research and unique thought leadership summits, we accelerate innovation to find solutions. To learn more, visit www.foodallergyfund.org.
Food Allergy Fund Announces $500k Drug Repurposing Challenge
Nov 30, 2023 — The Food Allergy Fund, a non-profit committed to bridging the funding gap for scientific research into food allergies, announced today it is accepting proposals for its Repurposing Innovators Research Grant. The grant(s) will be awarded to the researcher or team of researchers who demonstrates the most innovative approach to repurposing an existing FDA-approved drug for prevention of onset of food allergies, prevention or treatment of food anaphylaxis, or an improved therapeutic for maintaining food allergic tolerance in previously allergic patients.
Nov 30, 2023 — The Food Allergy Fund, a non-profit committed to bridging the funding gap for scientific research into food allergies, announced today it is accepting proposals for its Repurposing Innovators Research Grant. The grant(s) will be awarded to the researcher or team of researchers who demonstrates the most innovative approach to repurposing an existing FDA-approved drug for prevention of onset of food allergies, prevention or treatment of food anaphylaxis, or an improved therapeutic for maintaining food allergic tolerance in previously allergic patients.
Food Allergies are an emerging public health crisis that affect 1 in 13 children and 1 in 10 adults in the United States alone That's two children per classroom – a 50% increase from 1997 to 2011. Every three minutes, a person visits the emergency room due to an allergic reaction.
“The rising number of people living with food allergies is unacceptable and I am committed to supporting new research to turn the numbers upside down,” said Golant. “I have assembled an impressive Scientific Advisory Board to screen and select grant recipients to fund ground-breaking ideas into the underlying causes and improved treatments for all food allergies.”
The Food Allergy Fund’s Scientific Advisory Board includes immunologists, clinicians, microbiologists, gastroenterologists, and chemical engineers from institutions such as Columbia, Harvard, Johns Hopkins, MIT, Mount Sinai, NYU Langone, Stanford, and Yale and brings a comprehensive perspective on the research. The full list of Board members can be found at https://foodallergyfund.org/scientific-advisory-board.
To submit a research proposal for the innovators grant, please submit a two-page letter of intent with a copy of your CV to research@foodallergyfund.org.
Please note the following:
Proposals will be reviewed by the SAB and scored on the NIH scoring scale (1-9). Innovation and collaboration (across disciplines and/or institutions) will be prioritized in the scoring process.
The top scoring candidates based on the letter of intent and CV will be notified and requested to submit more detailed proposals.
Grant recipient(s) indirect costs are capped at 10%.
Grants will start at $100k per project, but may range in size depending on the scope of the project. A total of $500k in funding is available for this challenge.
All 2024 grant applicants must be willing to create a short video (10-15 minutes) presentation that will be pre-recorded by the Food Allergy Fund. The video should be a vibrant description of your proposal and will be shown at the FAF Summit in Spring 2024. Not all applicants will be selected for this opportunity.
###
The Food Allergy Fund is the leading nonprofit dedicated to funding food allergy research. FAF aims to identify underlying causes, discover new therapeutics, and improve the lives of all people living with food allergies. Through our ground-breaking research and unique thought leadership summits, we accelerate innovation to find solutions. To learn more, visit www.foodallergyfund.org.
Food Allergy Fund Announces $500,000 Microbiome Challenge
New York, NY (April 5, 2022) — The Food Allergy Fund, a non-profit committed to bridging the funding gap for scientific research into food allergies, announced today it is accepting proposals for its first Microbiome Challenge. The grant(s) will be awarded to the researcher or team of researchers with the most evidence based and innovative approach to mitigating the causes and symptoms of food allergies via the skin and gut microbiome. The grant(s) will be awarded up to $500,000.
Calls for Proposals Inspiring the Most Innovative Ideas for Skin and Gut Microbiome Approaches To Food Allergy
New York, NY (April 5, 2022) — The Food Allergy Fund, a non-profit committed to bridging the funding gap for scientific research into food allergies, announced today it is accepting proposals for its first Microbiome Challenge. The grant(s) will be awarded to the researcher or team of researchers with the most evidence based and innovative approach to mitigating the causes and symptoms of food allergies via the skin and gut microbiome. The grant(s) will be awarded up to $500,000.
Food Allergies are an emerging public health crisis. Six million children—out of 32 million Americans overall—are affected by food allergies. That's two children per classroom – a 50% increase from 1997 to 2011. Every three minutes, a person visits the emergency room due to an allergic reaction.
Yet research on causes and treatment is severely underfunded. Which is why Ilana Golant created the Food Allergy Fund: FAF’s mission is to raise awareness and money for scientific research. This mission is personal as Ilana is a mother to a child with food allergies.
“The rising number of people living with food allergies is grave and dangerous and I am committed to supporting new research to turn the numbers upside down,” said Golant. “I’ve assembled an impressive Scientific Advisory Board to screen and select grant recipients to fund ground-breaking ideas into the underlying causes and improved treatments for all food allergies.”
The Food Allergy Fund’s Scientific Advisory Board includes immunologists, clinicians, microbiologists, gastroenterologists, and chemical engineers from institutions such as Columbia, Harvard, Johns Hopkins, MIT, Mount Sinai, NYU Langone, Stanford, and Yale and brings a comprehensive perspective on the research. The full list of Board members can be found below and at https://foodallergyfund.org/scientific-advisory-board/.
To submit a research proposal for the Microbiome Challenge, please submit a two-page letter of intent with a copy of your CV to research@foodallergyfund.org by May 5, 2022.
Please note the following:
Proposals will be reviewed by the SAB and scored on the NIH scoring scale (1-9). Innovation and collaboration (across disciplines and/or institutions) will be prioritized in the scoring process.
The top scoring candidates based on the letter of intent and CV will be notified and requested to submit more detailed proposals.
Grant recipient(s) indirect costs are capped at 10%.
All 2022 grant applicants must be willing to create a short video (10-15 minutes) presentation that will be pre-recorded by the Food Allergy Fund. The video should be a vibrant description of your proposal and may be shown at the FAF Summit in December 2022. Not all applicants will be selected for this opportunity.
Please note that funding for this Challenge will in part be provided by Janssen Biotech, Inc. As such, FAF reserves the right to share proposals with relevant third parties.
Media contact: press@foodallergyfund.org
###
The Food Allergy Fund is the leading nonprofit dedicated to funding food allergy research. FAF aims to identify underlying causes, discover new therapeutics, and improve the lives of all people living with food allergies. Through our ground-breaking research and unique thought leadership summits, we accelerate innovation to find solutions. To learn more, visit www.foodallergyfund.org.
The Scientific Advisory Board
Henry Rutgers Chair of the Human Microbiome
Professor, Department of Medicine and Microbiology
Director, Center for Advanced Biotechnology and Medicine
RBHS, Robert Wood Johnson Medical School
Director, Boyd Lab for Human Immunology
Member, Child Health Research Institute
Member, Sean N. Parker Center for Allergy & Asthma Research
Associate Professor of Pathology
Stanford University School of Medicine
Stephanie Eisenbarth, M.D., Ph.D.
Chief, Division of Allergy and Immunology
Director, Center for Human Immunobiology
Northwestern University Feinberg School of Medicine
Director, Psychosocial Clinical Program, Division of Allergy &
Immunology Assistant Professor, Division of Psychology & Behavioral
Health Children's National Health System
Chief, Division of Gastroenterology, Hepatology and Nutrition
Boston Children's Hospital
Director, Harvard Digestive Diseases Center
Professor of Chemical Engineering
Massachusetts Institute of Technology (MIT)
Associate Member, Broad Institute
Associate Member, Ragon Institute of MGH, MIT and Harvard
Chief of the Division of Clinical Immunology
Merksamer Professor in Immunology
Icahn School of Medicine at Mount Sinai
Director, Sean N. Parker Center for Allergy and Asthma Research
Naddisy Foundation Endowed Professor of Medicine and Pediatrics
Stanford University School of Medicine
Assistant Professor of Immunobiology
Yale University School of Medicine
Kurt Hirschhorn Professor of Pediatrics
Director Emeritus, Jaffe Food Allergy Institute
Past President, American Academy of Allergy, Asthma & Immunology
Icahn School of Medicine at Mount Sinai
Wayne G. Shreffler, M.D., Ph.D.
Chief, Pediatric Allergy & Immunology
Director, Food Allergy Center
Massachusetts General Hospital
Associate Professor of Pediatrics, Harvard Medical School
Director, Elliot and Roslyn Jaffe Food Allergy Institute
Chief, Division of Allergy and Immunology, Department of Pediatrics
Icahn School of Medicine at Mount Sinai
Co-Chair, Consortium of Food Allergy Research (CoFAR)
National Institutes of Health (NIH)
Chair, Department of Environmental Health and Engineering
Johns Hopkins Bloomberg School of Public Health
Director, Molecular Biology Core
Associate Chief for Research, Division of Gastroenterology
Associate Director, Center for Molecular Studies in Digestive and Liver Disease
Ferdinand G. Weisbrod Professor in Gastroenterology
Hospital of the University of Pennsylvania